Description
Latin name
Neovir
Release form
The solution for i / m administration is transparent, greenish-yellow.
Packaging
2 ml – ampoules of dark glass (5) – blister strip packaging (1) – packs of cardboard.
Indications
As an immunostimulating agent in combination therapy: prevention and treatment of influenza and other acute respiratory diseases (including against the background of immunodeficiency states)
infections caused by Herpes simplex type 1 and 2 virus and Varicella zoster virus (in including in individuals with immune system disorders)
cytomegalovirus infection in individuals with
immunodeficiency radiation immunodeficiency
HIV treatment
encephalitis and encephalomyelitis viral etiology
acute and chronic hepatitis B and C srdlp retrites, epididymitis, prostatitis, cervicitis and salpingitis of chlamydial etiology
venereal lymphogranuloma
oncological diseases
multiple sclerosis
candidiasis of the skin and mucous membranes.
Contraindications
severe renal failure (CC less than 30 ml / min)
autoimmune diseases
pregnancy
lactation (breastfeeding)
childhood
hypersensitivity to the components of the drug.
Use with caution in elderly patients.
Use during pregnancy and lactation
The drug is contraindicated in pregnancy and lactation (breastfeeding).
Composition
1 ml
oxo dihydroacridinyl acetate 125 mg
Excipients: sodium citrate 2.5 mg, citric acid monohydrate 0.5-1.5 mg (up to pH 7.5-8.3), water d / and up to 1 ml.
Dosage and administration
Injection solution is administered in oil, a single dose is 250 mg (1 amp.) or 4-6 mg / kg of body weight. If necessary, a single dose of Neovir can be increased to 500 mg.
The course of treatment, if not specifically indicated, consists of 5-7 i / m injections in single doses with an interval of 48 hours. The course dose depends on the clinical picture. The duration of the course is 8-12 days. With prolonged and preventive use, the interval between Neovir injections is 3-7 days.
In HIV infections, the injection is used as part of combination therapy. The course of treatment consists of 10 i / m injections of 250 mg with an interval between injections of 48 hours. After a course of therapy, a break of 2 months is taken. The number of repeated courses is not limited.
Side effects
General reactions: low-grade fever, allergic reactions.
Local reactions: local, rapidly passing pain at the injection site.
Drug Interaction
No incompatibilities or potentiation of the drug when interacting with other medicinal products have been reported during clinical trials and use of the drug.
There is no information on the physico-chemical incompatibility of Neovir with other medicines.
Overdose
Overdose on Neovir is not provided.
Storage conditions
List B. The drug should be stored in a dry, dark place, out of reach of children at a temperature of 15 ° to 25 ° C.
A cloudy solution for injection to a milky white color indicates a violation of storage conditions and unsuitability for use.
The Expiration of
is 3 years.
Deystvuyuschee substances
Krydanymod
Conditions of supply of pharmacies
Prescription
Pharmsintez PAO, Russia
